Mechanistically, THBS2 promotes CRC metastasis by modulating the WNT/β-catenin signaling pathway while suppressing antitumor immunity through HIF1A/lactate/GPR132 axis interactions (19). This evidence concerns the gene THBS2 and colorectal carcinoma.